What NinePoint Medical does

NinePoint Medical, Inc. is a privately held medical device company founded in 2008 and headquartered in Austin, Texas, that develops the NvisionVLE Imaging System — a volumetric laser endomicroscopy (VLE) platform based on Advanced Optical Coherence Tomography (OCT) technology licensed from the Wellman Center for Photomedicine at Massachusetts General Hospital. The system provides real-time, cross-sectional imaging of esophageal tissue microstructure at 7 micron resolution and 3mm depth across a 6cm segment, generating 1,200 cross-sectional images per scan, and incorporates a Real-time Targeting feature that allows clinicians to laser-mark areas of suspicion during standard endoscopy procedures for downstream biopsy. The IRIS ML/AI add-on provides machine-learning-based pattern detection on anonymized OCT scan data, available to academic and medical research communities via public cloud and to clinics owning NvisionVLE consoles.

The company generates revenue through the sale of NvisionVLE consoles and dedicated consumable probe catheters (14mm, 17mm, 20mm balloon catheters and a 7Fr low-profile probe), an IRIS AI subscription/recurring layer, and optical endomicroscopy interpretation services billed under CPT code 88375. It operates an enterprise direct field-sales motion targeting gastroenterologists and clinical endoscopists in U.S. hospitals and medical centers, supported by dedicated reimbursement and clinical training resources. The system is indicated as an imaging tool for tissue microstructure evaluation; diagnostic-analysis safety and effectiveness have not been evaluated.

NinePoint has raised approximately $122.7M across equity rounds (Series A/B 2010, Series C 2014, Series D 2015) and debt facilities (Hercules Capital 2013, Horizon Technology Finance 2015) from investors including Prospect Venture Partners, Third Rock Ventures, Corning, Hercules Capital, and Horizon Technology Finance. No further financings, M&A activity, leadership changes, or product launches are disclosed after November 2015. The company maintains a U.S.-only footprint with 51–100 employees.

Name

NinePoint Medical

Legal name

NinePoint Medical, Inc.

Website

https://ninepointmedical.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

51–100 employees

Short description

NinePoint Medical is a private medical device company that develops and sells the NvisionVLE Imaging System, an OCT-based endoscopic imaging platform with an IRIS AI add-on, targeting U.S. gastroenterologists and clinical researchers evaluating esophageal tissue microstructure.

Ownership category

akta.pro rank

Product category

Medical Imaging Devices - Endoscopic Optical Coherence Tomography

NAICS

Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841), Optical Instruments & Lenses (3827)

akta.pro primary industry

Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB)

akta.pro secondary industries

AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG), Medical Imaging AI (HDAAAEAH), Imaging Informatics & Workflow (PACS/RIS/VNA) (HLAHABAI)

Keywords

• Optical coherence tomography
• Volumetric laser endomicroscopy
• Esophageal imaging devices
• Endoscopic imaging systems
• Medical imaging catheters

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

1. NvisionVLE Imaging System Hardware Sales: Sale of the NvisionVLE Imaging System console and optical probes to healthcare providers. The system includes a console, hand-controller, and balloon catheter probes available in 14mm, 17mm, 20mm sizes, as well as balloon-less 7 French Low-Profile optical probe.
2. Optical Probe Catheters: Recurring sales of balloon catheter probes for optical probe positioning and centering during procedures. Catheters are available in multiple sizes (14mm, 17mm, 20mm) and as balloon-less variants.
3. IRIS AI Analysis Solution: IRIS machine learning/AI solution provided to clinics that own NvisionVLE consoles to assist in data analyses. Available through public cloud access.
4. Optical Endomicroscopy Interpretation Services: CPT code 88375 covers optical endomicroscopic image interpretation and reporting, either real-time or referred, per endoscopic session.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

NinePoint Medical develops and sells the NvisionVLE Imaging System with Real-time Targeting, a volumetric laser endomicroscopy (VLE) platform that uses advanced optical coherence tomography to provide real-time, cross-sectional imaging of esophageal tissue microstructure at 7 micron resolution to a depth of 3mm. The company also sells disposable balloon catheter optical probes and offers the IRIS machine learning/artificial intelligence solution for pattern detection in OCT scan data, available to clinics owning the console and to academic/medical research institutions via the public cloud.

Product overview

NinePoint Medical offers a unified medical imaging platform centered on the NvisionVLE Imaging System with Real-time Targeting, which combines Advanced OCT technology for volumetric tissue imaging with the IRIS ML/AI add-on module for pattern detection. The core system provides real-time cross-sectional imaging of esophageal tissue microstructure at 7 micron resolution, while IRIS enables automated analysis of scan data to assist clinicians in identifying areas of concern.

Differentiator

Problem solved

Functional benefit

Brands

• IRIS: ML/AI solution for pattern detection in OCT scans, providing anonymized clinical data analysis for academic and medical research communities, and available for clinics owning NvisionVLE consoles.
• NvisionVLE Imaging System with Real-time Targeting

Products and services

• NvisionVLE Imaging System with Real-time Targeting Capital medical imaging system using advanced OCT to provide real-time cross-sectional imaging of esophageal tissue microstructure at 7 micron resolution and 3mm depth, with Real-time Targeting to laser-mark suspicious areas during endoscopy. Sold to gastroenterologists, clinical endoscopists, hospitals, and academic medical centers.
• Optical Probe Catheters (Balloon and Balloon-less) Disposable optical probe catheters used with the NvisionVLE Imaging System to position and center the optics in the esophagus during VLE procedures, available in 14mm, 17mm, 20mm balloon variants and a 7 French Low-Profile balloon-less variant for recurring procedure revenue.
• IRIS ML/AI Pattern Detection Solution Machine learning/artificial intelligence software that assists with pattern detection and anomaly identification in OCT scan data, available via the public cloud for academic and medical research users and as an add-on module for clinics owning NvisionVLE consoles.

Quantifiable outcome

• 3mm depth penetration beneath mucosa at 7 micron resolution, compared to white light endoscopy which images only surface detail
• +3 more outcomes

Named customers7 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Partnerships

One partnership is on record.

• Wellman Center for Photomedicine at Massachusetts General HospitalcoreTechnology or IntegrationNinePoint Medical's Advanced OCT technology is licensed from the Wellman Center for Photomedicine at Massachusetts General Hospital. This licensing agreement provides the foundational technology for the NvisionVLE Imaging System, enabling next-generation Optical Coherence Tomography imaging capabilities for esophageal tissue microstructure evaluation.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Medtronic: Large diversified medical device company with a meaningful presence in GI diagnostics, AI-assisted endoscopy (GI Genius), and hospital capital sales channels. Medtronic's installed base of AI-enabled endoscopy products creates direct overlap with NinePoint's positioning around advanced imaging and pattern detection in the GI suite.
• Carl Zeiss Meditec: Global leader in optical coherence tomography systems, primarily in ophthalmology but with ongoing R&D into broader OCT applications. Zeiss shares the foundational swept-source OCT technology stack that NinePoint relies on and represents the dominant commercial OCT franchise globally.
• Boston Scientific: Major endoscopy and GI capital equipment manufacturer with a broad portfolio of therapeutic and diagnostic devices used by the same gastroenterologist customers NinePoint targets. Boston Scientific's scale in GI sales channels and growing imaging/AI investments create both partnership opportunities and competitive overlap.
• Pentax Medical (HOYA Corporation): Endoscopy OEM and direct competitor for GI capital equipment sales. Pentax serves the same gastroenterology customer base with comparable console platforms, making it a natural head-to-head competitor at the procurement stage and a potential integration partner for advanced imaging modules.
• Fujifilm Healthcare: Endoscopy system manufacturer with established AI/advanced imaging features (e.g., BLI, LCI) integrated into its GI consoles. Competes for the same gastroenterology capital budget and is increasingly layering AI into imaging workflows analogous to NinePoint's IRIS offering.
• Olympus Corporation: Global leader in endoscopy systems and the dominant capital equipment vendor in gastroenterology. Olympus sells the endoscopy stacks into which NinePoint's optical probes integrate and has been actively adding AI-enabled lesion detection to its platforms, making it both a channel dependency and a competitive threat in advanced GI imaging.

Emerging players

• NIDEK: Manufacturer of ophthalmic diagnostic equipment including OCT systems, with a presence in advanced optical imaging for clinical use. Comparable through its use of OCT technology and clinical specialty imaging sales motion, though primarily serving ophthalmology rather than gastroenterology.
• Heidelberg Engineering: Specialized OCT imaging company with strong presence in ophthalmic and research OCT platforms. Comparable through its core technology focus on OCT imaging and its enterprise sales motion into clinical and research institutions similar to NinePoint's installed-base profile.
• Visionix (formerly Optovue): OCT and multi-modal imaging specialist serving ophthalmology and optometry practices with a focus on AI-augmented image analysis. Comparable to NinePoint through its use of OCT as the foundational imaging modality and the addition of AI-driven analytics on top of the imaging data, although operating in a different clinical specialty.
• Perimeter Medical Imaging AI: AI-powered medical imaging company developing advanced imaging and pattern recognition tools for surgical and pathology applications. Shares NinePoint's core thesis of layering AI/ML onto high-resolution imaging data for clinical decision support, although focused on surgical margins rather than esophageal endoscopy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/139909972801820
• LinkedInlinkedin.com/company/ninepoint-medical

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds5 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NinePoint Medical